142 related articles for article (PubMed ID: 10342092)
1. Cardiovascular risks: perception versus reality.
Mishell DR
Contraception; 1999 Jan; 59(1 Suppl):21S-24S. PubMed ID: 10342092
[TBL] [Abstract][Full Text] [Related]
2. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
Beaumont V; Lemort N; Beaumont JL
Eur Heart J; 1991 Nov; 12(11):1219-24. PubMed ID: 1782953
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraception and risk of cardiovascular disease. An international perspective.
Farley TM; Collins J; Schlesselman JJ
Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
[TBL] [Abstract][Full Text] [Related]
7. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
8. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
Fruzzetti F; Ricci C; Fioretti P
Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of oral contraceptives and cardiovascular disease.
Chasan-Taber L; Stampfer MJ
Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
[TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
Lewis MA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S68-77. PubMed ID: 9753313
[TBL] [Abstract][Full Text] [Related]
11. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
Thorogood M; Vessey MP
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
[TBL] [Abstract][Full Text] [Related]
12. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
Endrikat J; Müller U; Düsterberg B
Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers.
Stanczyk FZ; Ploszaj S; Gentzschein E; Qian D; Mishell DR
Contraception; 1999 Jan; 59(1):17-23. PubMed ID: 10342082
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
Nalbanski B; Tsekova K; Ivanov S
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
[No Abstract] [Full Text] [Related]
15. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
Schwingl PJ; Ory HW; Visness CM
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
18. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
19. [Combined oral contraceptives with extremely low doses of estrogen (15 micrograms in a single tablet)].
Cepický P; Dvorák K; Holub Z; Uzel R
Ceska Gynekol; 2001 Jul; 66(4):297-9. PubMed ID: 11569429
[No Abstract] [Full Text] [Related]
20. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
